CTSA Program Collaborative Innovation Awards
The University of Maryland, Baltimore (UMB) and Johns Hopkins University (JHU) forge a powerful alliance with the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA). The CTSA program helps support high-quality translational clinical research locally, regionally, and nationally and fosters innovation in research methods, training, and career development. As a CTSA Program hub (1UL1TR003098-01), UMB now has additional NIH U01 and R21 funding opportunities that would not otherwise be available.
The CTSA Program Collaborative Innovation Award (CCIA) supports collaborative research activities that develop innovative solutions that will improve the efficiency, quality and impact of turning laboratory, clinic and community observations into interventions that improve the health of individuals and the public. The CCIA U01 Collaborative Innovation Award support investigators from three or more CTSA Program hub institutions and the R21 Exploratory/Developmental Innovation Awards support investigators from two or more CTSA Program hub institutions to either:
1) form new collaborations, or to
2) significantly expand the scientific scope of existing collaborations, or to
3) engage new collaborators in pre-existing collaborations
to solve a translational science problem no one hub can solve alone, or disseminate a solution to a translational science problem developed at one hub to other hubs, in so doing testing its robustness to different hub environments and structures and adapting it for further dissemination within outside the CTSA Program consortium if appropriate.
Please visit the CTSA FAQ page for information https://ncats.nih.gov/ctsa/funding/innovation-faq#par